BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23936758)

  • 1. Role of E3 ubiquitin ligases in lung cancer.
    Snoek BC; de Wilt LH; Jansen G; Peters GJ
    World J Clin Oncol; 2013 Aug; 4(3):58-69. PubMed ID: 23936758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting E3 ubiquitin ligases for cancer therapy.
    Sun Y
    Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ubiquitin ligases as cancer targets and biomarkers.
    Sun Y
    Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of E3 ubiquitin ligases in gastric cancer.
    Hou YC; Deng JY
    World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.
    Wei D; Sun Y
    Genes Cancer; 2010 Jul; 1(7):700-7. PubMed ID: 21103004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 ubiquitin ligases: styles, structures and functions.
    Yang Q; Zhao J; Chen D; Wang Y
    Mol Biomed; 2021 Jul; 2(1):23. PubMed ID: 35006464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of approaches for screening for ubiquitin ligase inhibitors.
    Sun Y
    Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions.
    Cai W; Yang H
    Cell Div; 2016; 11():7. PubMed ID: 27222660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
    Satija YK; Bhardwaj A; Das S
    Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 Ubiquitin Ligases in Neurological Diseases: Focus on Gigaxonin and Autophagy.
    Lescouzères L; Bomont P
    Front Physiol; 2020; 11():1022. PubMed ID: 33192535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
    Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
    Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
    Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
    Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
    Zhou W; Wei W; Sun Y
    Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cullin-RING Ligases as attractive anti-cancer targets.
    Zhao Y; Sun Y
    Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of TGF-beta family signaling by E3 ubiquitin ligases.
    Inoue Y; Imamura T
    Cancer Sci; 2008 Nov; 99(11):2107-12. PubMed ID: 18808420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.
    Pray TR; Parlati F; Huang J; Wong BR; Payan DG; Bennett MK; Issakani SD; Molineaux S; Demo SD
    Drug Resist Updat; 2002 Dec; 5(6):249-58. PubMed ID: 12531181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted modulation of E3 ligases using engineered ubiquitin variants.
    LeBlanc N; Mallette E; Zhang W
    FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.